RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Liver Neoplasms |
|
Accession: | DOID:9007188
|
browse the term
|
Synonyms: | exact_synonym: | NEOPLASM OF THE LIVER; hepatic neoplasm; hepatic neoplasms; liver neoplasm; neoplasm of liver |
| primary_id: | MESH:D008113 |
| xref: | EFO:1001513 |
|
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27193730 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Abtb3 |
ankyrin repeat and BTB domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 7:18,035,151...18,310,718
Ensembl chr 7:18,036,083...18,310,834
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Adamts17 |
ADAM metallopeptidase with thrombospondin type 1 motif, 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 1:120,445,800...120,768,204
Ensembl chr 1:120,445,749...120,768,202
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19996281 PMID:30346592 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa4 |
annexin A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Anxa7 |
annexin A7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Neoplasm of the liver |
CTD ClinVar |
PMID:16569251 PMID:18199528 PMID:21859464 PMID:22703879 PMID:23159591 PMID:24728327 PMID:25186627 PMID:25479140 PMID:25741868 PMID:25980754 PMID:26173098 PMID:26252958 PMID:26467025 PMID:26530882 PMID:26580448 PMID:26837502 PMID:26845104 PMID:26976419 PMID:27064257 PMID:27121310 PMID:28135048 PMID:28135145 PMID:28195569 PMID:28492532 PMID:32088909 PMID:32390703 PMID:32984025 More...
|
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apcs |
amyloid P component, serum |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20195826 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Ash1l |
ASH1 like histone lysine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27064257 |
|
NCBI chr 2:174,346,267...174,483,057
Ensembl chr 2:174,346,150...174,483,055
|
|
G |
Asip |
agouti signaling protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15175105 |
|
NCBI chr 3:143,473,584...143,561,170
Ensembl chr 3:143,555,696...143,561,171
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atp7b |
ATPase copper transporting beta |
onset |
ISO IAGP |
CTD Direct Evidence: marker/mechanism compared to LEC/Tj; |
CTD RGD |
PMID:11509115 PMID:11509115 |
RGD:1302456 |
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Atp7bhts |
ATPase copper transporting beta; hepatitis |
onset |
IAGP |
compared to LEC/Tj; |
RGD |
PMID:11509115 |
RGD:1302456 |
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231345 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17514646 |
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Ccdc134 |
coiled-coil domain containing 134 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 7:113,644,557...113,659,050
Ensembl chr 7:113,644,639...113,659,050
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27064257 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnh |
cyclin H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33010264 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16391232 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12378512 PMID:16317707 PMID:27064257 PMID:33010264 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33010264 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852
|
|
G |
Chn2 |
chimerin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 PMID:28108177 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Clstn2 |
calsyntenin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
|
|
G |
Csf2 |
colony stimulating factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17326190 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:9018096 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10467420 PMID:21047994 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33010264 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33010264 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17093202 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
|
|
G |
Ddx54 |
DEAD-box helicase 54 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr12:35,934,713...35,949,956
Ensembl chr12:35,934,716...35,972,523
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24478143 |
|
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dpp10 |
dipeptidyl peptidase like 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr13:34,584,420...36,269,292
Ensembl chr13:34,595,868...36,269,292
|
|
G |
Efnb2 |
ephrin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Esm1 |
endothelial cell-specific molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16712894 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Exosc2 |
exosome component 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 3:14,962,930...14,973,645
Ensembl chr 3:14,962,917...14,973,575
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12112319 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Flcn |
folliculin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26411935 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Fst |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12203361 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Gadl1 |
glutamate decarboxylase-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 8:115,605,609...115,785,676
Ensembl chr 8:115,605,873...115,784,410
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2559087 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gnmt |
glycine N-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21137059 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30641053 |
|
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment |
ISO |
|
RGD |
PMID:26147624 |
RGD:152995453 |
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20195826 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21214675 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Hcfc1 |
host cell factor C1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19255062 |
|
NCBI chr X:151,687,779...151,712,688
Ensembl chr X:151,687,779...151,712,638
|
|
G |
Hebp2 |
heme binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr 1:13,194,982...13,201,777
Ensembl chr 1:13,194,982...13,201,777
|
|
G |
Herc3 |
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 4:87,952,202...88,042,492
Ensembl chr 4:87,952,274...88,042,488
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8807143 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Higd2a |
HIG1 hypoxia inducible domain family, member 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr17:10,021,853...10,022,777
Ensembl chr17:10,021,859...10,022,796
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17002867 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10874023 PMID:12082015 PMID:12127263 PMID:16410370 PMID:17514646 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Ifna1 |
interferon, alpha 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:14633663 |
|
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Ift88 |
intraflagellar transport 88 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9362446 |
|
NCBI chr15:31,573,325...31,666,068
Ensembl chr15:31,573,376...31,672,147
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12127304 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17326190 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17326190 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18298334 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 |
|
NCBI chr16:6,122,246...6,136,363
Ensembl chr16:6,122,248...6,136,363
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12127263 PMID:24183702 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10629081 PMID:12211074 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krt18 |
keratin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19409407 PMID:19796649 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19409407 PMID:19796649 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Large1 |
LARGE xylosyl- and glucuronyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr19:11,603,129...12,048,930
Ensembl chr19:11,603,129...12,048,930
|
|
G |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 5:50,370,744...51,687,252
Ensembl chr 5:50,367,101...50,516,956
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12079509 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Macir |
macrophage immunometabolism regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr 9:98,420,760...98,440,818
Ensembl chr 9:98,420,376...98,441,733
|
|
G |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27064257 |
|
NCBI chr 3:127,720,066...129,737,511
Ensembl chr 3:127,720,181...129,734,492
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17468757 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mir148a |
microRNA 148a |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:32268151 |
|
NCBI chr 4:80,333,762...80,333,858
Ensembl chr 4:80,333,762...80,333,858
|
|
G |
Mir29a |
microRNA 29a |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21175813 |
|
NCBI chr 4:59,650,608...59,650,695
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33010264 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8807143 PMID:11532874 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myo5b |
myosin Vb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr18:68,038,759...68,341,568
Ensembl chr18:68,038,759...68,338,745
|
|
G |
Nat2 |
N-acetyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19666988 |
|
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27064257 |
|
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15341671 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:20722399 PMID:35523338 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nop16 |
NOP16 nucleolar protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr17:10,022,950...10,027,867
Ensembl chr17:10,022,932...10,027,867
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23178280 PMID:24091600 PMID:24189133 PMID:29142166 PMID:30556042 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 PMID:19482888 PMID:22293087 PMID:24449422 PMID:28218408 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nudcd3 |
NudC domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr14:80,976,330...81,059,183
Ensembl chr14:80,976,328...81,058,962
|
|
G |
Nudt7 |
nudix hydrolase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr19:42,125,679...42,151,198
Ensembl chr19:42,125,711...42,151,081
|
|
G |
Oat |
ornithine aminotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
|
|
G |
Pdrg1 |
p53 and DNA damage regulated 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 3:141,477,561...141,483,730
Ensembl chr 3:141,476,501...141,483,858 Ensembl chr 3:141,476,501...141,483,858
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Pls1 |
plastin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 |
|
NCBI chr 8:96,316,703...96,426,592
Ensembl chr 8:96,317,849...96,385,195
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20143881 PMID:29134746 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20143881 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prickle2 |
prickle planar cell polarity protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 4:124,869,655...125,214,862
Ensembl chr 4:124,869,552...125,214,824
|
|
G |
Prkce |
protein kinase C, epsilon |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
|
|
G |
Psma4 |
proteasome 20S subunit alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20195826 |
|
NCBI chr 8:55,340,431...55,347,893
Ensembl chr 8:55,340,386...55,347,890
|
|
G |
Pter |
phosphotriesterase related |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr17:76,058,388...76,119,633
Ensembl chr17:76,058,503...76,119,627
|
|
G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 PMID:20163174 |
|
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19499222 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rtp3 |
receptor (chemosensory) transporter protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17693185 |
|
NCBI chr 8:110,970,154...110,975,000
Ensembl chr 8:110,970,160...110,974,699
|
|
G |
Scd |
stearoyl-CoA desaturase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12419843 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Six3 |
SIX homeobox 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 6:9,039,017...9,043,336
Ensembl chr 6:9,036,434...9,053,301
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26943884 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc38a9 |
solute carrier family 38, member 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 2:44,291,637...44,374,897
Ensembl chr 2:44,291,989...44,368,955
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21785164 |
|
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
|
|
G |
Slc66a3 |
solute carrier family 66 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 |
|
NCBI chr 6:39,774,801...39,786,554
Ensembl chr 6:39,774,808...39,786,303
|
|
G |
Snhg11 |
small nucleolar RNA host gene 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 |
|
NCBI chr 3:147,031,367...147,037,043
|
|
G |
Snx10 |
sorting nexin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr 4:80,612,648...80,677,005
Ensembl chr 4:80,612,669...80,676,996
|
|
G |
Spata21 |
spermatogenesis associated 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 5:153,393,309...153,419,430
Ensembl chr 5:153,393,365...153,418,561
|
|
G |
Srms |
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 3:168,318,511...168,324,915
Ensembl chr 3:168,318,512...168,324,915
|
|
G |
Stac3 |
SH3 and cysteine rich domain 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12957465 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
exacerbates |
ISO |
B6 strain |
RGD |
PMID:24838184 |
RGD:153298928 |
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Tcf4 |
transcription factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27064257 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tgfa |
transforming growth factor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8807143 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tmem132d |
transmembrane protein 132D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr12:28,270,039...28,917,324
Ensembl chr12:28,270,712...28,915,374
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24183702 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18980244 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr11:68,114,725...68,154,254
Ensembl chr11:68,114,726...68,154,009
|
|
G |
Top1 |
DNA topoisomerase I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30132517 |
|
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
|
|
G |
Top2a |
DNA topoisomerase II alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30132517 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tox3 |
TOX high mobility group box family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28108177 |
|
NCBI chr19:16,648,338...16,757,151
Ensembl chr19:16,648,342...16,757,148
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12378512 PMID:16410370 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trio |
trio Rho guanine nucleotide exchange factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 2:78,505,069...78,801,384
Ensembl chr 2:78,505,070...78,803,135
|
|
G |
Trmt11 |
tRNA methyltransferase 11 homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr 1:27,054,437...27,109,765
Ensembl chr 1:27,054,420...27,201,610
|
|
G |
Ttc39a |
tetratricopeptide repeat domain 39A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 |
|
NCBI chr 5:124,165,102...124,204,740
Ensembl chr 5:124,151,760...124,204,973
|
|
G |
Ttll9 |
tubulin tyrosine ligase like 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 3:141,429,351...141,475,965
Ensembl chr 3:141,429,444...141,475,865
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 |
|
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Wdr17 |
WD repeat domain 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr16:37,059,923...37,191,125
Ensembl chr16:37,059,895...37,191,122
|
|
G |
Wscd1 |
WSC domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr10:56,385,858...56,426,442
Ensembl chr10:56,395,874...56,424,677
|
|
G |
Xpa |
XPA, DNA damage recognition and repair factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24084170 |
|
NCBI chr 5:60,431,673...60,475,726
Ensembl chr 5:60,431,673...60,475,726
|
|
G |
Xpc |
XPC complex subunit, DNA damage recognition and repair factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24084170 |
|
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
|
|
G |
Yif1a |
Yip1 interacting factor homolog A, membrane trafficking protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 1:202,394,923...202,399,125
Ensembl chr 1:202,394,897...202,399,427
|
|
G |
Zdhhc2 |
zinc finger DHHC-type palmitoyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25058030 PMID:28108177 |
|
NCBI chr16:51,808,465...51,878,060
Ensembl chr16:51,808,468...51,878,060
|
|
G |
Zscan22 |
zinc finger and SCAN domain containing 22 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19233941 |
|
NCBI chr 1:73,516,328...73,527,766
Ensembl chr 1:73,516,395...73,527,697
|
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
IEP |
associated with estrogen excess;protein:increased activity;liver (rat) |
RGD |
PMID:6133380 |
RGD:152998935 |
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
IEP |
associated with estrogen excess;protein:increased activity;liver (rat) |
RGD |
PMID:6133380 |
RGD:152998935 |
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
ClinVar Annotator: match by term: Pediatric hepatocellular carcinoma |
ClinVar |
PMID:9927037 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
|
IDA |
|
RGD |
PMID:15853769 |
RGD:1598580 |
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
|
IEP |
|
RGD |
PMID:8104413 |
RGD:5684351 |
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Adsl |
adenylosuccinate lyase |
|
IEP |
protein:increased activity:liver (rat) |
RGD |
PMID:2937404 |
RGD:1598766 |
NCBI chr 7:112,479,256...112,503,439
Ensembl chr 7:112,479,271...112,503,760
|
|
G |
Afp |
alpha-fetoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24012840 PMID:32961231 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agps |
alkylglycerone phosphate synthase |
|
IDA |
|
RGD |
PMID:7407223 |
RGD:1598794 |
NCBI chr 3:60,747,323...60,845,831
Ensembl chr 3:60,747,323...60,845,830
|
|
G |
Alas2 |
5'-aminolevulinate synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
|
|
G |
Apoa4 |
apolipoprotein A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoc2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression |
ISO |
|
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Arrb2 |
arrestin, beta 2 |
|
IEP |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:21167192 |
RGD:5509890 |
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Atp7a |
ATPase copper transporting alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23792645 |
|
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
|
|
G |
Atp7b |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23792645 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28100771 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28100771 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10426811 PMID:28100771 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10426811 PMID:28100771 PMID:22414765 |
RGD:11353865 |
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:18246794 |
RGD:2293125 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
IEP |
protein:increased activity:liver (rat) |
RGD |
PMID:13618893 |
RGD:5132586 |
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
|
|
G |
Car3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30603057 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccnb1 |
cyclin B1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:17342310 |
RGD:2315991 |
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:28100771 PMID:17055752 |
RGD:2289139 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccndbp1 |
cyclin D1 binding protein 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16501603 |
|
NCBI chr 3:107,962,402...107,974,234
Ensembl chr 3:107,962,261...107,974,233
|
|
G |
Ccng1 |
cyclin G1 |
|
ISO |
|
RGD |
PMID:27982046 |
RGD:151361200 |
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccng2 |
cyclin G2 |
|
ISO |
|
RGD |
PMID:27982046 |
RGD:151361200 |
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
|
RGD |
PMID:19035311 |
RGD:5491179 |
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd63 |
Cd63 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20118494 PMID:25319454 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
IEP |
protein:decreased expression:liver: |
RGD |
PMID:8640740 |
RGD:8662309 |
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
disease_progression |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:19533683 |
RGD:2315050 |
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
disease_progression |
IEP |
protein:decreased expression:liver (rat) protein:increased expression:liver (rat) mRNA:increased expression:liver (rat) |
RGD |
PMID:26606000 PMID:3965145 PMID:19533683 |
RGD:11354707, RGD:152998958, RGD:2315050 |
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cops5 |
COP9 signalosome subunit 5 |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:26606000 |
RGD:11354707 |
NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23792645 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
severity |
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:3387993 |
RGD:2303406 |
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11280770 PMID:20118494 PMID:21147764 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:22687991 |
RGD:7296954 |
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11376689 PMID:21147764 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18056438 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Dhodh |
dihydroorotate dehydrogenase |
|
IEP |
protein:increased activity:liver (rat) |
RGD |
PMID:6331524 |
RGD:5132618 |
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
G |
Dtymk |
deoxythymidylate kinase |
|
IEP |
protein:increased activity:tumor (rat) |
RGD |
PMID:6244089 |
RGD:5133686 |
NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870
|
|
G |
Eno2 |
enolase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2910524 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
IEP |
|
RGD |
PMID:7260898 |
RGD:11252158 |
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35044086 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
F12 |
coagulation factor XII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30737368 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Foxm1 |
forkhead box M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15082532 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18308698 PMID:1336494 |
RGD:7349398 |
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
|
IEP |
|
RGD |
PMID:1336494 |
RGD:7349398 |
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Glul |
glutamate-ammonia ligase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20118494 PMID:21147764 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Grp |
gastrin releasing peptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2910524 |
|
NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
IEP ISO |
protein:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:2563599 PMID:3124819 PMID:7585603 PMID:20188851 PMID:12016164 PMID:3965145 More...
|
RGD:2317823, RGD:152998958 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
|
IDA ISO |
DNA:hypomethylation:promoter CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11420682 PMID:15352122 |
RGD:1342455 |
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
Hat1 |
histone acetyltransferase 1 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:17182829 |
RGD:2316578 |
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11896611 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
|
IEP |
protein:increased expression:brainstem, cerebral cortex |
RGD |
PMID:17258772 |
RGD:1624998 |
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
|
|
G |
Igf2 |
insulin-like growth factor 2 |
treatment |
IEP |
|
RGD |
PMID:22425635 |
RGD:10402567 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
|
IAGP |
|
RGD |
PMID:15057872 PMID:9652747 |
RGD:2311623, RGD:2311630 |
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30737368 |
|
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
|
|
G |
Il6 |
interleukin 6 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (mouse) |
CTD RGD |
PMID:26297436 PMID:26569409 |
RGD:11344640 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Insr |
insulin receptor |
disease_progression |
IEP |
associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat) |
RGD |
PMID:15520221 |
RGD:2306052 |
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28100771 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Kat6a |
lysine acetyltransferase 6A |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:17083329 |
RGD:2312274 |
NCBI chr16:69,084,914...69,165,923
Ensembl chr16:69,084,914...69,163,606
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11956651 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
disease_progression |
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat) |
CTD RGD |
PMID:8603461 PMID:19533683 |
RGD:2315050 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
IEP |
associated with Diabetes Mellitus, Experimental;protein:increased expression:liver |
RGD |
PMID:15520221 |
RGD:2306052 |
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28100771 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28100771 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11956651 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mfge8 |
milk fat globule EGF and factor V/VIII domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
|
|
G |
Mir10a |
microRNA 10a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
|
|
G |
Mir125a |
microRNA 125a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
|
|
G |
Mir145 |
microRNA 145 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
|
|
G |
Mir151 |
microRNA 151 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 7:105,172,377...105,172,473
|
|
G |
Mir181c |
microRNA 181c |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr19:23,983,523...23,983,628
Ensembl chr19:23,983,523...23,983,628
|
|
G |
Mir181d |
microRNA 181d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr19:23,983,706...23,983,788
Ensembl chr19:23,983,706...23,983,788
|
|
G |
Mir183 |
microRNA 183 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 4:58,788,614...58,788,723
Ensembl chr 4:58,788,614...58,788,723
|
|
G |
Mir186 |
microRNA 186 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 2:246,582,806...246,582,891
Ensembl chr 2:246,582,806...246,582,891
|
|
G |
Mir18a |
microRNA 18a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr15:98,587,984...98,588,079
Ensembl chr15:92,180,765...92,180,860
|
|
G |
Mir193a |
microRNA 193a |
|
ISO |
miRNA:decreased expression:liver (mouse) |
RGD |
PMID:30165047 |
RGD:153323340 |
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
|
|
G |
Mir195 |
microRNA 195 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr10:54,951,838...54,951,924
Ensembl chr10:54,951,838...54,951,924
|
|
G |
Mir196b |
microRNA 196b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 4:81,330,487...81,330,571
Ensembl chr 4:81,330,487...81,330,571
|
|
G |
Mir200b |
microRNA 200b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
|
|
G |
Mir206 |
microRNA 206 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:23,094,249...23,094,332
|
|
G |
Mir212 |
microRNA 212 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr10:60,023,403...60,023,513
Ensembl chr10:60,023,403...60,023,513
|
|
G |
Mir221 |
microRNA 221 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
|
|
G |
Mir26a |
microRNA 26a |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 8:118,755,289...118,755,378
Ensembl chr 8:118,755,289...118,755,378
|
|
G |
Mir26b |
microRNA 26b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 9:75,976,596...75,976,680
Ensembl chr 9:75,976,596...75,976,680
|
|
G |
Mir290 |
microRNA 290 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 1:65,964,648...65,964,728
Ensembl chr 1:65,964,648...65,964,728
|
|
G |
Mir300 |
microRNA 300 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 6:128,738,513...128,738,591
Ensembl chr 6:128,738,505...128,738,594
|
|
G |
Mir301a |
microRNA 301a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr10:71,925,336...71,925,435
Ensembl chr10:71,925,336...71,925,435
|
|
G |
Mir30a |
microRNA 30a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
|
|
G |
Mir30b |
microRNA 30b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 7:100,132,589...100,132,675
Ensembl chr 7:100,132,589...100,132,675
|
|
G |
Mir30d |
microRNA 30d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 7:100,136,391...100,136,472
Ensembl chr 7:100,136,391...100,136,472
|
|
G |
Mir30e |
microRNA 30e |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 5:134,352,232...134,352,323
Ensembl chr 5:134,352,232...134,352,323
|
|
G |
Mir324 |
microRNA 324 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr10:54,734,680...54,734,762
Ensembl chr10:54,734,678...54,734,766
|
|
G |
Mir331 |
microRNA 331 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 7:28,527,390...28,527,485
Ensembl chr 7:28,527,390...28,527,485
|
|
G |
Mir336 |
microRNA 336 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr10:34,185,579...34,185,674
Ensembl chr10:34,185,579...34,185,674
|
|
G |
Mir339 |
microRNA 339 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr12:15,277,546...15,277,641
Ensembl chr12:15,277,546...15,277,641
|
|
G |
Mir340 |
microRNA 340 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr10:34,393,568...34,393,665
Ensembl chr10:34,393,568...34,393,665
|
|
G |
Mir347 |
microRNA mir-347 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
|
|
G |
Mir349 |
microRNA 349 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 7:120,243,311...120,243,407
Ensembl chr 7:120,243,311...120,243,407
|
|
G |
Mir34a |
microRNA 34a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
|
|
G |
Mir352 |
microRNA mir-352 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
|
|
G |
Mir383 |
microRNA 383 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr16:54,040,340...54,040,413
Ensembl chr16:54,040,340...54,040,413
|
|
G |
Mir409 |
microRNA 409 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 6:128,757,780...128,757,856
Ensembl chr 6:128,757,779...128,757,858
|
|
G |
Mir429 |
microRNA 429 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 5:166,647,459...166,647,543
Ensembl chr 5:166,647,459...166,647,543
|
|
G |
Mir598 |
microRNA 598 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr15:37,962,692...37,962,770
Ensembl chr15:37,962,692...37,962,771
|
|
G |
Mir652 |
microRNA 652 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr X:106,343,293...106,343,373
Ensembl chr X:106,343,293...106,343,373
|
|
G |
Mir671 |
microRNA 671 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 4:10,580,747...10,580,827
Ensembl chr 4:10,580,738...10,580,835
|
|
G |
Mir708 |
microRNA 708 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 1:150,599,876...150,599,963
Ensembl chr 1:150,599,876...150,599,963
|
|
G |
Mir760 |
microRNA 760 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 2:210,392,616...210,392,695
Ensembl chr 2:210,392,616...210,392,695
|
|
G |
Mir92b |
microRNA 92b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 2:174,633,890...174,633,972
Ensembl chr 2:174,633,890...174,633,972
|
|
G |
Mir98 |
microRNA 98 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr X:20,981,235...20,981,342
Ensembl chr X:20,981,235...20,981,342
|
|
G |
Mir99b |
microRNA 99b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 1:58,677,015...58,677,084
Ensembl chr 1:58,677,011...58,677,090
|
|
G |
Mirlet7b |
microRNA let-7b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 7:116,804,186...116,804,270
Ensembl chr 7:116,804,186...116,804,270
|
|
G |
Mirlet7d |
microRNA let-7d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr17:16,115,893...16,115,990
Ensembl chr17:16,115,893...16,115,990
|
|
G |
Mirlet7i |
microRNA let-7i |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21035526 |
|
NCBI chr 7:58,642,485...58,642,569
Ensembl chr 7:58,642,480...58,642,571
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression, increased activity:liver |
CTD RGD |
PMID:30603057 PMID:19528495 PMID:19539802 |
RGD:2325736, RGD:2325734 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
mRNA, protein:increased expression, increased activity:liver |
RGD |
PMID:19528495 PMID:19539802 |
RGD:2325736, RGD:2325734 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpeg1 |
macrophage expressed 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
IEP ISO |
mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:9079223 PMID:11280770 PMID:18560566 PMID:3335218 |
RGD:10059623 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:10383909 |
RGD:2325277 |
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:18942116 |
RGD:2325310 |
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
|
IEP |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:27867096 |
RGD:13442478 |
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
susceptibility |
ISO |
|
RGD |
PMID:17283114 |
RGD:14701032 |
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17172636 PMID:24769335 PMID:25656644 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
human gene in mouse model |
RGD |
PMID:16286660 |
RGD:14975105 |
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:7929120 |
RGD:1642378 |
NCBI chr10:44,775,910...44,849,990
Ensembl chr10:44,775,911...44,850,013
|
|
G |
Plcl1 |
phospholipase C-like 1 |
disease_progression |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:19533683 |
RGD:2315050 |
NCBI chr 9:56,901,573...57,238,782
Ensembl chr 9:56,901,534...57,238,782
|
|
G |
Pml |
PML nuclear body scaffold |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20377131 |
|
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
|
|
G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:761203 |
|
NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144
|
|
G |
Ppp2ca |
protein phosphatase 2 catalytic subunit alpha |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:2562181 |
RGD:8693574 |
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
|
|
G |
Prdx1 |
peroxiredoxin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27517622 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:24853774 |
RGD:14401713 |
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Rad51 |
RAD51 recombinase |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:17219426 |
RGD:2292638 |
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17854601 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rgn |
regucalcin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
|
|
G |
Rida |
reactive intermediate imine deaminase A homolog |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:12939504 |
RGD:9685719 |
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
|
|
G |
Rras2 |
RAS related 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147764 |
|
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
|
IEP |
|
RGD |
PMID:15224347 |
RGD:2316863 |
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
|
|
G |
Rxra |
retinoid X receptor alpha |
|
IEP |
mRNA, protein:decreased expression:liver |
RGD |
PMID:17786350 |
RGD:1643105 |
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Serpina1 |
serpin family A member 1 |
|
IEP |
|
RGD |
PMID:10569800 |
RGD:1626391 |
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Slc31a1 |
solute carrier family 31 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23792645 |
|
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:17498859 |
RGD:151357003 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Snx27 |
sorting nexin 27 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36029209 |
|
NCBI chr 2:182,135,904...182,218,906
Ensembl chr 2:182,135,905...182,218,906
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15197228 |
|
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147764 |
|
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sqle |
squalene epoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26297436 PMID:28100771 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tek |
TEK receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11956651 |
|
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
|
|
G |
Tgfa |
transforming growth factor alpha |
|
IEP ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:9079223 PMID:16734725 |
RGD:2317490 |
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28100771 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tk1 |
thymidine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11420682 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tnf |
tumor necrosis factor |
disease_progression treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (mouse) Morris hepatoma |
CTD RGD |
PMID:28100771 PMID:26569409 PMID:9063767 |
RGD:11344640, RGD:14696818 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10626228 PMID:28100771 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tsc22d1 |
TSC22 domain family, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15833021 PMID:17533171 |
|
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
|
|
G |
Vim |
vimentin |
|
IDA |
|
RGD |
PMID:19199359 |
RGD:6480440 |
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xdh |
xanthine dehydrogenase |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:3460692 |
RGD:13210515 |
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Hnf1a |
HNF1 homeobox A |
|
ISO |
ClinVar Annotator: match by term: Hepatic adenomas, familial | ClinVar Annotator: match by term: LIVER CELL ADENOMAS, FAMILIAL CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:8866553 PMID:8945470 PMID:9032114 PMID:9045858 PMID:9075818 PMID:9166684 PMID:9313763 PMID:9392505 PMID:9439666 PMID:9754819 PMID:10333057 PMID:10447526 PMID:10754480 PMID:10966642 PMID:11058894 PMID:11296231 PMID:11315851 PMID:11393552 PMID:12050210 PMID:12355088 PMID:12530534 PMID:12574234 PMID:12618559 PMID:14747304 PMID:15649945 PMID:15883474 PMID:15928245 PMID:17054605 PMID:17407387 PMID:17440016 PMID:17573900 PMID:17937063 PMID:17989309 PMID:18003757 PMID:18672310 PMID:19169489 PMID:19929997 PMID:21051477 PMID:21628466 PMID:21696527 PMID:22348187 PMID:22432108 PMID:23348805 PMID:23551881 PMID:23607861 PMID:24097065 PMID:25174781 PMID:25555642 PMID:25741868 PMID:26059258 PMID:26431509 PMID:26467025 PMID:27148439 PMID:28395978 PMID:28492532 PMID:28862987 PMID:29417725 PMID:30191644 PMID:30293189 PMID:30455330 PMID:30814848 PMID:31264968 PMID:31365591 PMID:31517624 PMID:31576961 PMID:31638168 PMID:32238361 PMID:32395877 PMID:32741144 PMID:32910913 PMID:34373539 PMID:35328643 PMID:35673428 More...
|
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
|
G |
Car12 |
carbonic anhydrase 12 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:28304380 |
RGD:153352326 |
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
protein:increased tyrosine phosphorylation:exon: |
RGD |
PMID:19101982 |
RGD:14402052 |
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:24925055 |
RGD:11055933 |
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
|
ISO |
mRNA,protein:increased expression:liver (human) |
RGD |
PMID:27027723 |
RGD:151347845 |
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
|
ISO |
ClinVar Annotator: match by term: Hepatic hemangioma |
ClinVar |
PMID:33912852 |
|
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
|
|
|
G |
Tsc2 |
TSC complex subunit 2 |
|
IAGP |
DNA:mutations:multiple associated with tuberous sclerosis;DNA:mutations:multiple |
RGD |
PMID:29512829 PMID:22251200 |
RGD:21079730, RGD:21079732 |
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:1316610 PMID:8381579 PMID:8764128 PMID:9824584 PMID:15311282 PMID:17293347 PMID:20685668 PMID:22135120 PMID:27081525 PMID:28492532 PMID:35495172 More...
|
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
mRNA, protein:decreased expression:serum (human) |
RGD |
PMID:27974108 |
RGD:25671440 |
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:26822237 |
|
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:11756177 PMID:16832357 PMID:17333338 PMID:19781682 PMID:20305132 PMID:21665257 PMID:24728327 PMID:25085752 PMID:25186627 PMID:25741868 PMID:26467025 PMID:26689913 PMID:26787654 PMID:26837699 PMID:27913932 PMID:28492532 PMID:28779002 PMID:29522266 PMID:29659569 PMID:30256826 PMID:30303537 PMID:30995915 PMID:31780696 PMID:32325837 PMID:33128190 PMID:33359728 PMID:33436325 PMID:33471991 PMID:34262154 PMID:34646395 PMID:35264596 PMID:35495172 PMID:35980532 PMID:36099812 PMID:37436117 PMID:39085400 More...
|
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Axin2 |
axin 2 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:11809809 |
RGD:151356508 |
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:26467025 PMID:26580448 PMID:28492532 PMID:35264596 PMID:35495172 PMID:36187937 More...
|
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:9971877 PMID:10717622 PMID:15937982 PMID:17826769 PMID:19941162 PMID:21120943 PMID:21769658 PMID:23056405 PMID:23893897 PMID:24884479 PMID:25085752 PMID:25348012 PMID:25741868 PMID:26467025 PMID:26933808 PMID:27741520 PMID:28492532 PMID:30212499 PMID:31131967 PMID:31911673 PMID:33471991 PMID:33643918 PMID:35039564 PMID:35495172 PMID:35980532 More...
|
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
C8h11orf65 |
similar to human chromosome 11 open reading frame 65 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:21665257 PMID:25085752 PMID:25186627 PMID:25741868 PMID:26787654 PMID:28492532 PMID:29522266 PMID:33471991 PMID:35495172 PMID:36099812 PMID:39085400 More...
|
|
NCBI chr 8:53,796,033...53,825,277
Ensembl chr 8:53,796,366...53,824,748
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:16465411 |
RGD:14402053 |
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cldn1 |
claudin 1 |
severity |
IEP |
mRNA,protein:decreased expression:liver, embryonic tissue (human) |
RGD |
PMID:16647953 |
RGD:26884349 |
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Col7a1 |
collagen type VII alpha 1 chain |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hepatoblastoma protein:increased expression:cytoplasm,nucleus: |
CTD ClinVar RGD |
PMID:9500465 PMID:9927029 PMID:10192393 PMID:10398436 PMID:10435629 PMID:10655994 PMID:21237236 PMID:23265383 PMID:25741868 PMID:26822237 PMID:10398436 More...
|
RGD:14402054 |
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:12270273 PMID:15670717 PMID:16207203 PMID:16392899 PMID:23042628 PMID:24813812 PMID:25741868 PMID:27401223 PMID:28250423 PMID:28492532 PMID:29300326 More...
|
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dis3l2 |
DIS3-like 3'-5' exoribonuclease 2 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 PMID:35495172 |
|
NCBI chr 9:87,355,409...87,736,616
Ensembl chr 9:87,356,457...87,736,616
|
|
G |
Dock8 |
dedicator of cytokinesis 8 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 |
|
NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
|
|
G |
Dpep1 |
dipeptidase 1 |
ameliorates |
ISO |
human cells in mouse model |
RGD |
PMID:31541079 |
RGD:153344539 |
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
|
|
G |
Drosha |
drosha ribonuclease III |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr 2:61,864,886...61,976,688
Ensembl chr 2:61,864,970...61,976,688
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:24728327 PMID:25741868 PMID:28492532 PMID:29178624 |
|
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ercc5 |
ERCC excision repair 5, endonuclease |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
|
|
G |
Ext2 |
exostosin glycosyltransferase 2 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr 3:79,665,414...79,798,077
Ensembl chr 3:79,665,415...79,798,059
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fanca |
FA complementation group A |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:24728327 PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
|
|
G |
Fancd2 |
FA complementation group D2 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:28492532 PMID:28678401 PMID:30306255 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fancd2os |
FANCD2 opposite strand |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,740,863...146,747,547
Ensembl chr 4:146,740,863...146,747,569
|
|
G |
Fancm |
FA complementation group M |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 PMID:28678401 PMID:28881617 PMID:29351780 PMID:32522261 PMID:35495172 More...
|
|
NCBI chr 6:83,126,903...83,180,455
Ensembl chr 6:83,127,093...83,180,028
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
mRNA,protein:increased expression:hepatocyte: ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar RGD |
PMID:28492532 PMID:10398166 |
RGD:14700699 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 PMID:35495172 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fh |
fumarate hydratase |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
|
|
G |
Flcn |
folliculin |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 PMID:35495172 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Flna |
filamin A |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Frmpd1 |
FERM and PDZ domain containing 1 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr 5:59,443,076...59,545,125
Ensembl chr 5:59,443,076...59,545,080
|
|
G |
Gba1 |
glucosylceramidase beta 1 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:12204005 PMID:21228398 PMID:23430543 PMID:25741868 |
|
NCBI chr 2:174,609,437...174,615,457
Ensembl chr 2:174,609,403...174,618,263
|
|
G |
Gli3 |
GLI family zinc finger 3 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Gpc3 |
glypican 3 |
|
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:23530909 |
RGD:243065128 |
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23958494 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:36965188 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jmjd1c |
jumonji domain containing 1C |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 |
|
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:27666373 PMID:28492532 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mir193a |
microRNA 193a |
exacerbates |
ISO |
RNA:decreased expression:liver (human) |
RGD |
PMID:31541079 |
RGD:153344539 |
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
miRNA:increased expression:plasma, extracellular exosome |
RGD |
PMID:27601233 |
RGD:14695023 |
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir34a |
microRNA 34a |
severity |
ISO |
miRNA:increased expression:liver |
RGD |
PMID:27046304 |
RGD:14695006 |
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
ameliorates |
ISO |
human cells in mouse model |
RGD |
PMID:31541079 |
RGD:153344539 |
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Msh2 |
mutS homolog 2 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msh6 |
mutS homolog 6 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:28492532 PMID:35264596 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Mutyh |
mutY DNA glycosylase |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr 5:130,274,034...130,286,149
Ensembl chr 5:130,274,122...130,286,146
|
|
G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:12935928 |
RGD:9590075 |
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
|
|
G |
Ndrg4 |
NDRG family member 4 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,351,404...9,386,914
|
|
G |
Nynrin |
NYN domain and retroviral integrase containing |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr15:29,332,873...29,355,215
Ensembl chr15:29,332,869...29,355,215
|
|
G |
Pcna |
proliferating cell nuclear antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11560253 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Recql |
RecQ like helicase |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
|
|
G |
Recql4 |
RecQ like helicase 4 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
|
|
G |
Ren |
renin |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:28492532 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rhbdf2 |
rhomboid 5 homolog 2 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr10:101,833,157...101,860,283
Ensembl chr10:101,833,157...101,860,283
|
|
G |
Rps19 |
ribosomal protein S19 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:12586610 PMID:25741868 PMID:28492532 PMID:37897121 |
|
NCBI chr 1:80,480,718...80,486,511
Ensembl chr 1:80,480,951...80,486,508 Ensembl chr 7:80,480,951...80,486,508
|
|
G |
Sall1 |
spalt-like transcription factor 1 |
|
ISO |
embryonal subtype;protein:increased expression:liver, nucleus (human) |
RGD |
PMID:23822878 |
RGD:11556217 |
NCBI chr19:18,005,782...18,022,705
Ensembl chr19:18,007,503...18,022,705
|
|
G |
Sall4 |
spalt-like transcription factor 4 |
|
ISO |
Embryonal Hepatoblastoma;protein:increased expression:liver (human) |
RGD |
PMID:23822878 |
RGD:11556217 |
NCBI chr 3:157,474,067...157,491,055
Ensembl chr 3:157,474,642...157,490,822
|
|
G |
Sh2b3 |
SH2B adaptor protein 3 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:20404132 PMID:25741868 |
|
NCBI chr12:34,731,934...34,753,617
Ensembl chr12:34,731,911...34,753,616
|
|
G |
Slx4 |
SLX4 structure-specific endonuclease subunit |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr10:11,526,623...11,549,313
Ensembl chr10:11,528,424...11,549,295
|
|
G |
Smo |
smoothened, frizzled class receptor |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:21159571 |
RGD:150521618 |
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Spop |
speckle type BTB/POZ protein |
|
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:24912477 |
RGD:153298925 |
NCBI chr10:80,358,121...80,438,983
Ensembl chr10:80,358,124...80,483,955
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
|
|
G |
Tgfa |
transforming growth factor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11560253 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
|
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:1565143 PMID:8401536 PMID:8633021 PMID:12826609 PMID:17606709 PMID:19556618 PMID:20128691 PMID:20586629 PMID:21343334 PMID:22887876 PMID:23031740 PMID:23259501 PMID:25584008 PMID:25741868 PMID:26467025 PMID:26585234 PMID:26911350 PMID:27189670 PMID:28279309 PMID:28492532 PMID:28975465 PMID:29070607 PMID:29979965 PMID:30224644 PMID:31775759 PMID:32475984 PMID:32817165 PMID:33087929 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
ISO |
ClinVar Annotator: match by term: Hepatoblastoma |
ClinVar |
PMID:7563486 PMID:8634692 PMID:8707293 PMID:8772572 PMID:8956040 PMID:9829911 PMID:9829912 PMID:10567493 PMID:10612827 PMID:10761708 PMID:11106358 PMID:11257211 PMID:11739384 PMID:12202531 PMID:12414898 PMID:15300849 PMID:19228690 PMID:19574279 PMID:19906784 PMID:20447124 PMID:22234250 PMID:23990664 PMID:23990666 PMID:24033266 PMID:24055113 PMID:25637381 PMID:25741868 PMID:26211615 PMID:27527340 PMID:28492532 PMID:28503092 PMID:29790589 PMID:30877234 More...
|
|
NCBI chr 4:146,772,483...146,779,376
Ensembl chr 4:146,772,468...146,779,377
|
|
G |
Zfhx3 |
zinc finger homeobox 3 |
|
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:33368532 |
RGD:151361168 |
NCBI chr19:36,257,196...36,886,104
Ensembl chr19:36,630,254...36,881,771
|
|
|
G |
A2m |
alpha-2-macroglobulin |
|
IEP ISO |
mRNA,protein:increased expression:liver: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15509519 PMID:15509519 |
RGD:1358261 |
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
|
IEP |
mRNA,protein:increased expression:liver: |
RGD |
PMID:23912631 |
RGD:9586718 |
NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17620307 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147764 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
treatment |
IEP |
|
RGD |
PMID:23543859 |
RGD:14700918 |
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10959800 |
|
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Hnf1a |
HNF1 homeobox A |
susceptibility exacerbates |
IAGP ISO |
DNA:loss of heterozygosity, mutations:multiple DNA:mutation: (human) DNA:frameshift mutation, non-sense mutation:cds:R229X, G55fsX57 (human) |
RGD |
PMID:12355088 PMID:17663417 PMID:14598263 |
RGD:14700683, RGD:150530291, RGD:14700774 |
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hp |
haptoglobin |
|
IEP |
|
RGD |
PMID:10569800 |
RGD:1626391 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8200073 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
induced |
IAGP |
aflatoxin B1 induced:DNA:transversion,transition mutations:cds: |
RGD |
PMID:8446626 |
RGD:11568697 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
ameliorates |
ISO |
|
RGD |
PMID:26560698 |
RGD:11342977 |
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31939706 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
ISO |
|
RGD |
PMID:17183066 |
RGD:14696794 |
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25656644 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:27022031 PMID:15199412 |
RGD:1302555 |
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISS |
|
MouseDO |
|
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Tmem70 |
transmembrane protein 70 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27914986 |
|
NCBI chr 5:2,637,102...2,654,729
Ensembl chr 5:2,637,102...2,654,729
|
|
G |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27914986 |
|
NCBI chr15:6,980,241...7,257,912
Ensembl chr15:6,980,474...7,257,532
|
|
|
G |
A2m |
alpha-2-macroglobulin |
|
IEP ISO |
mRNA,protein:increased expression:liver: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15509519 PMID:15509519 |
RGD:1358261 |
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aadat |
aminoadipate aminotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr16:29,509,392...29,544,332
Ensembl chr16:29,509,394...29,544,332
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
severity |
IEP ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:16941710 PMID:30580964 |
RGD:1598532, RGD:24922199 |
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
susceptibility |
IEP ISO |
DNA:polymorphism: :c.3751G>A(human) DNA:polymorphism: : c.1465C > T(human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17510421 PMID:25625052 PMID:24175826 PMID:23488625 |
RGD:11041138, RGD:14700905, RGD:14700904 |
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
|
ISO ISS |
CTD Direct Evidence: marker/mechanism OMIM:114550 |
CTD MouseDO |
PMID:22022477 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:25842354 |
RGD:11535155 |
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abce1 |
ATP binding cassette subfamily E member 1 |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:21932399 |
RGD:11041873 |
NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:32171747 |
RGD:126907997 |
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Ace |
angiotensin I converting enzyme |
susceptibility |
ISO |
CTD Direct Evidence: therapeutic DNA:insertion/deletion:intron 16: |
CTD RGD |
PMID:16328049 PMID:25208933 |
RGD:11343535 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acer3 |
alkaline ceramidase 3 |
disease_progression |
ISO |
|
RGD |
PMID:30097213 |
RGD:35673325 |
NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
|
|
G |
Acly |
ATP citrate lyase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Aco2 |
aconitase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12771043 PMID:15565109 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Actb |
actin, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 PMID:21472284 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19514085 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adamts13 |
ADAM metallopeptidase with thrombospondin type 1 motif, 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 3:10,299,264...10,338,464
Ensembl chr 3:10,300,028...10,346,687
|
|
G |
Add1 |
adducin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Adgrg7 |
adhesion G protein-coupled receptor G7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr11:43,808,101...43,877,539
Ensembl chr11:43,813,801...43,876,316
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
susceptibility |
ISO |
DNA:SNP:intron:+276T>G (rs1501299) (human) |
RGD |
PMID:23740135 |
RGD:14401720 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
|
|
G |
Afp |
alpha-fetoprotein |
severity treatment disease_progression |
ISO IEP |
protein:increased expression:serum (human) CTD Direct Evidence: marker/mechanism associated with hepatitis B |
CTD RGD |
PMID:9029167 PMID:15276417 PMID:24012840 PMID:28284560 PMID:32961231 PMID:22147961 PMID:25999787 PMID:22392353 PMID:25968302 PMID:28611981 More...
|
RGD:14401581, RGD:152177911, RGD:125097525, RGD:126790583, RGD:126790579 |
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Aicda |
activation-induced cytidine deaminase |
|
ISO |
|
RGD |
PMID:18997814 |
RGD:127285629 |
NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
|
|
G |
Ak3 |
adenylate kinase 3 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:17203974 |
RGD:13842477 |
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32805337 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
|
ISO IEP |
protein:increased expression:liver (human) protein:increased expression:liver (rat) |
RGD |
PMID:19422879 PMID:21683810 |
RGD:8548685, RGD:5509919 |
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
exacerbates treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver |
CTD RGD |
PMID:32045588 PMID:37460115 PMID:25999787 PMID:31801250 |
RGD:408364960, RGD:152177911, RGD:151893509 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
IEP ISO |
protein:increased phosphorylation:liver cancer cell (rat) protein:increased phosphorylation:liver (mouse) |
RGD |
PMID:19309364 PMID:28100771 |
RGD:2313299, RGD:127285675 |
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alb |
albumin |
susceptibility |
ISO |
protein:decreased expression:serum (human) associated with hepatitis C;protein:decreased expression:serum |
RGD |
PMID:23892757 PMID:22392353 PMID:29040987 |
RGD:11035269, RGD:125097525, RGD:14694841 |
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
susceptibility no_association severity |
ISO |
associated with alcoholic liver cirrhosis;DNA:missense mutation:cds:p.E487K (human) associated with alcohol use disorder;DNA:missense mutation:cds: (human) DNA:missense mutation:exon 12: (human) associated with hepatitis B;DNA;missense mutation, haplotype:cds: (rs671) (human) DNA:missense mutation:cds: (rs671) (human) mRNA, protein:decreased expression:liver (human) protein:decreased expression: liver (human) associated with hepatitis C:DNA:SNP:exon 12 (human) DNA:missense mutation:cds, exon 12:p.E487K (human) |
RGD |
PMID:25778454 PMID:18439068 PMID:10737710 PMID:26827895 PMID:29765251 PMID:28027570 PMID:26150517 PMID:12940444 PMID:1916152 More...
|
RGD:11054822, RGD:15042862, RGD:15042859, RGD:15042857, RGD:14700899, RGD:15036809, RGD:14696779, RGD:14696778, RGD:14696699 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
severity |
ISO |
mRNA:altered expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:3830170 |
RGD:2301136 |
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alx4 |
ALX homeobox 4 |
ameliorates |
ISO IEP |
mRNA, protein:decreased expression:liver |
RGD |
PMID:28081728 PMID:31132711 PMID:31132711 |
RGD:153323329, RGD:153323330, RGD:153323330 |
NCBI chr 3:79,611,682...79,648,260
Ensembl chr 3:79,611,719...79,648,260
|
|
G |
Angptl6 |
angiopoietin-like 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
|
|
G |
Ank3 |
ankyrin 3 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:26652480 |
RGD:153344559 |
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Anln |
anillin, actin binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Antxr1 |
ANTXR cell adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:20650339 |
RGD:9684932 |
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
|
|
G |
Anxa10 |
annexin A10 |
disease_progression |
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:33675609 |
RGD:152999436 |
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa4 |
annexin A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Anxa6 |
annexin A6 |
disease_progression |
ISO |
associated with tumor vascularization; protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO ISS |
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma OMIM:114550 CTD Direct Evidence: marker/mechanism DNA:hypermethylation |
OMIM ClinVar MouseDO CTD RGD |
PMID:1316610 PMID:8381579 PMID:8381580 PMID:9536098 PMID:9585611 PMID:9824584 PMID:10713886 PMID:11001924 PMID:11247896 PMID:11317365 PMID:11466687 PMID:11748858 PMID:15311282 PMID:15459959 PMID:16461775 PMID:17293347 PMID:17411426 PMID:17489848 PMID:17576681 PMID:17963004 PMID:18199528 PMID:19531215 PMID:19793053 PMID:20223039 PMID:20685668 PMID:21859464 PMID:21901162 PMID:22135120 PMID:22425061 PMID:22431159 PMID:22447671 PMID:22703879 PMID:23159591 PMID:23460355 PMID:23484150 PMID:24033266 PMID:24448499 PMID:24573554 PMID:24599579 PMID:24728327 PMID:25186627 PMID:25479140 PMID:25559809 PMID:25590978 PMID:25637381 PMID:25741868 PMID:25925381 PMID:25980754 PMID:26207792 PMID:26447891 PMID:26467025 PMID:26530882 PMID:26580448 PMID:26690363 PMID:26845104 PMID:26900293 PMID:26976419 PMID:27028212 PMID:27081525 PMID:27150160 PMID:27600092 PMID:27852271 PMID:28051113 PMID:28127413 PMID:28135048 PMID:28135145 PMID:28195569 PMID:28492532 PMID:28526081 PMID:29641532 PMID:29684080 PMID:30267214 PMID:30374176 PMID:30458888 PMID:31428572 PMID:32390703 PMID:32658311 PMID:33294277 PMID:34426522 PMID:35189564 PMID:35264596 PMID:28203651 More...
|
RGD:14402050 |
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apcs |
amyloid P component, serum |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25109342 PMID:33841550 |
RGD:152998960 |
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apln |
apelin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
|
|
G |
Apoa1 |
apolipoprotein A1 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism associated with hepatitis B; protein:decreased expression:plasma (human) |
CTD RGD |
PMID:21472284 PMID:31211449 PMID:23935864 |
RGD:153350082, RGD:25671438 |
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoa2 |
apolipoprotein A2 |
|
ISO |
associated with hepatitis B; mRNA:increased expression:liver |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
|
|
G |
Apoa4 |
apolipoprotein A4 |
disease_progression |
ISO |
associated with hepatitis B; |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoc1 |
apolipoprotein C1 |
disease_progression |
ISO |
associated with hepatitis B; |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apoc2 |
apolipoprotein C2 |
|
ISO |
associated with hepatitis B; mRNA:increased expression:liver |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
|
|
G |
Apoc3 |
apolipoprotein C3 |
susceptibility disease_progression |
ISO |
associated with Chronic Hepatitis B;DNA:SNP: :rs2854116(human) associated with hepatitis B; |
RGD |
PMID:27547913 PMID:31211449 |
RGD:153344620, RGD:153350082 |
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Apoc4 |
apolipoprotein C4 |
disease_progression |
ISO |
associated with hepatitis B; |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chr 1:79,335,745...79,339,942
Ensembl chr 1:79,335,745...79,339,981
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
protein:increased expression:liver, serum (mouse) |
RGD |
PMID:21644509 |
RGD:6903288 |
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Apof |
apolipoprotein F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
|
|
G |
Aprt |
adenine phosphoribosyl transferase |
|
IEP |
protein:increased activity:hepatoma (rat) |
RGD |
PMID:6327016 |
RGD:5135035 |
NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431
|
|
G |
Ar |
androgen receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18639551 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg1 |
arginase 1 |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:17210712 PMID:30901224 |
RGD:4140476, RGD:152995286 |
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap11a |
Rho GTPase activating protein 11A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
exacerbates |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:31136984 |
RGD:401901276 |
NCBI chr10:49,655,583...49,822,876
Ensembl chr10:49,655,584...49,824,297
|
|
G |
Arhgef39 |
Rho guanine nucleotide exchange factor 39 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 5:57,752,509...57,756,079
Ensembl chr 5:57,752,509...57,756,109
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
exacerbates treatment |
ISO |
CTD Direct Evidence: marker/mechanism human gene in mouse model associated with non-alcoholic steatohepatitis mRNA, protein:decreased expression:liver (human) mRNA, protein:increased expression:liver (human) |
CTD RGD |
PMID:22561517 PMID:22634756 PMID:22922871 PMID:29136504 PMID:29136504 PMID:26569409 PMID:29113912 PMID:25975202 PMID:26589513 More...
|
RGD:126790634, RGD:126790634, RGD:11344640, RGD:125097519, RGD:125097495, RGD:125097485 |
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Arid1b |
AT-rich interaction domain 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22634756 |
|
NCBI chr 1:45,567,991...45,923,644
Ensembl chr 1:45,563,623...45,923,493
|
|
G |
Arid2 |
AT-rich interaction domain 2 |
disease_progression exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism associated with hepatitis B;protein:decreased expression:liver |
CTD RGD |
PMID:21822264 PMID:22634756 PMID:25701229 PMID:28498550 PMID:27351279 PMID:32071245 More...
|
RGD:150429631, RGD:150340712, RGD:150340711, RGD:150340708 |
NCBI chr 7:127,447,192...127,565,987
Ensembl chr 7:127,447,278...127,563,512
|
|
G |
Arid3a |
AT-rich interaction domain 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35179300 |
|
NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
|
|
G |
Arrb2 |
arrestin, beta 2 |
treatment |
IEP |
|
RGD |
PMID:33841550 |
RGD:152998960 |
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Asl |
argininosuccinate lyase |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
IEP |
protein:increased activity:serum (rat) |
RGD |
PMID:10081 |
RGD:2316006 |
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Aspg |
asparaginase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
|
|
G |
Aspm |
assembly factor for spindle microtubules |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:28284560 PMID:18676753 |
RGD:13439743 |
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:12359751 PMID:30901224 |
RGD:4140479, RGD:152995286 |
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atg101 |
autophagy related 101 |
disease_progression |
ISO |
|
RGD |
PMID:35592424 |
RGD:153350091 |
NCBI chr 7:132,398,477...132,407,643
Ensembl chr 7:132,398,483...132,407,633
|
|
G |
Atg7 |
autophagy related 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29191453 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Atm |
ATM serine/threonine kinase |
exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) |
CTD RGD |
PMID:12866955 PMID:19919837 |
RGD:126781750 |
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
|
ISO |
associated with hepatitis C |
RGD |
PMID:18932288 |
RGD:14696822 |
NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Aurka |
aurora kinase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Axin1 |
axin 1 |
disease_progression |
ISO |
ClinVar Annotator: match by term: AXIN1-related condition | ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma protein:decreased expression:liver (human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype:exon:(rs1805105) T>C (human) CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM RGD |
PMID:10700176 PMID:25741868 PMID:25822088 PMID:28492532 PMID:37582359 PMID:10700176 PMID:31514071 PMID:22960659 PMID:26968103 More...
|
RGD:1300371, RGD:150530482, RGD:150530481, RGD:14402039 |
NCBI chr10:15,163,477...15,215,615
Ensembl chr10:15,163,684...15,215,615
|
|
G |
Axin2 |
axin 2 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:11809809 |
RGD:151356508 |
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
disease_progression |
ISO IEP |
mRNA:decreased expression:liver |
RGD |
PMID:22625427 PMID:26902423 PMID:27993894 |
RGD:153350130, RGD:153350133, RGD:153350132 |
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
Azin1 |
antizyme inhibitor 1 |
disease_progression |
ISO |
RNA:increased editing:liver |
RGD |
PMID:23291631 |
RGD:14700705 |
NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
|
|
G |
Banf1 |
barrier to autointegration nuclear assembly factor 1 |
treatment |
IEP ISO |
mRNA, protein:increased expression:liver (rat) mRNA, protein:increased expression:liver (human) |
RGD |
PMID:29059470 PMID:29059470 PMID:29059470 |
RGD:155791679, RGD:155791679, RGD:155791679 |
NCBI chr 1:202,672,170...202,674,215
Ensembl chr 1:202,671,305...202,674,188
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:33841550 |
RGD:152998960 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
ISO IEP |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:28100771 PMID:33841550 |
RGD:127285675, RGD:152998960 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (mouse) |
CTD RGD |
PMID:10629087 PMID:11509945 PMID:33841550 PMID:28100771 |
RGD:152998960, RGD:127285675 |
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bco2 |
beta-carotene oxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 8:50,882,174...50,907,676
Ensembl chr 8:50,882,181...50,915,467
|
|
G |
Bcorl1 |
BCL6 co-repressor-like 1 |
disease_progression |
ISO |
|
RGD |
PMID:29679906 PMID:26879601 |
RGD:150340705, RGD:11556159 |
NCBI chr X:127,516,504...127,584,529
Ensembl chr X:127,537,538...127,584,087
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bhmt2 |
betaine-homocysteine S-methyltransferase 2 |
severity |
ISO |
mRNA:altered expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15289866 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
ameliorates treatment exacerbates |
ISO |
human cell line in a mouse model mRNA, protein:increased expression:liver (human) associated with hepatitis B;mRNA, protein:increased expression:liver (human) |
RGD |
PMID:30368883 PMID:30210622 PMID:33310033 PMID:22820591 PMID:22682366 |
RGD:152998937, RGD:152999010, RGD:152998988, RGD:152998986, RGD:152998984 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (human) |
CTD RGD |
PMID:16086872 PMID:20514400 PMID:31964418 |
RGD:153344516 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Birc7 |
baculoviral IAP repeat-containing 7 |
exacerbates |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
|
|
G |
Blzf1 |
basic leucine zipper nuclear factor 1 |
disease_progression |
ISO |
|
RGD |
PMID:26342799 |
RGD:14398326 |
NCBI chr13:76,641,757...76,656,977
Ensembl chr13:76,641,515...76,656,999
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
treatment |
ISO |
|
RGD |
PMID:26919246 |
RGD:14928318 |
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Bmper |
BMP-binding endothelial regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27222248 |
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Bsg |
basigin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36574092 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18393292 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C3 |
complement C3 |
|
IEP |
|
RGD |
PMID:23245919 |
RGD:11040806 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C6h14orf180 |
similar to human chromosome 14 open reading frame 180 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 6:131,557,193...131,568,245
Ensembl chr 6:131,559,690...131,567,342
|
|
G |
C9 |
complement C9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
|
|
G |
Cab39 |
calcium binding protein 39 |
disease_progression |
ISO |
|
RGD |
PMID:28605041 PMID:28605041 |
RGD:14398832, RGD:14398832 |
NCBI chr 9:86,463,095...86,524,545
Ensembl chr 9:86,463,095...86,524,544
|
|
G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
IEP IAGP |
mRNA:increased expression:liver DNA:amplification:cds (rat) |
RGD |
PMID:2888462 PMID:7053379 PMID:2914957 |
RGD:2303530, RGD:10755426, RGD:5132587 |
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
|
IEP |
DNA, mRNA, protein:hypermethylation, decreased expression:promoter:liver |
RGD |
PMID:17428255 |
RGD:2289095 |
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
disease_progression |
ISO |
mRNA, protein:decreased expression:liver |
RGD |
PMID:24240726 |
RGD:15092075 |
NCBI chr11:4,548,367...5,525,420
Ensembl chr11:4,555,159...5,525,400
|
|
G |
Calml3 |
calmodulin-like 3 |
severity |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:29445139 |
RGD:151665319 |
NCBI chr17:66,419,844...66,423,083
Ensembl chr17:66,419,882...66,423,175
|
|
G |
Calr |
calreticulin |
exacerbates treatment |
ISO |
protein:increased expression:liver (human) human cells and recombinant gene in a mouse model |
RGD |
PMID:27055635 PMID:24997628 PMID:12096119 |
RGD:150521681, RGD:150521691, RGD:150521690 |
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
ISO |
|
RGD |
PMID:23651211 |
RGD:18337283 |
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Cap2 |
cyclase associated actin cytoskeleton regulatory protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr17:18,054,234...18,203,453
Ensembl chr17:18,054,431...18,203,373
|
|
G |
Capn3 |
calpain 3 |
|
IEP |
mRNA:decreased expression:skeletal muscle |
RGD |
PMID:10806331 |
RGD:1600777 |
NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:107,407,850...107,457,858
|
|
G |
Car12 |
carbonic anhydrase 12 |
disease_progression ameliorates |
ISO |
mRNA:altered expression:liver |
RGD |
PMID:35362480 PMID:29900055 PMID:31934040 PMID:35362480 |
RGD:153352325, RGD:155226869, RGD:153352328, RGD:153352325 |
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car9 |
carbonic anhydrase 9 |
|
ISO |
mRNA:altered expression:liver |
RGD |
PMID:29900055 |
RGD:155226869 |
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
|
IEP |
mRNA,protein:increased expression:liver: |
RGD |
PMID:23912631 |
RGD:9586718 |
NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:29133031 PMID:33841550 |
RGD:13782296, RGD:152998960 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
severity treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism associated with hepatitis B;DNA:insertion/deletion:promoter: (rs3834129) (human) |
OMIM CTD RGD |
PMID:28643196 PMID:29133031 |
RGD:14695027, RGD:13782296 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
treatment |
IEP |
|
RGD |
PMID:29133031 |
RGD:13782296 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
disease_progression |
ISO |
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-262T>C (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:33010264 PMID:21907168 |
RGD:27095879 |
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbfb |
core-binding factor subunit beta |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:17094378 |
RGD:126775147 |
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
|
|
G |
Cbl |
Cbl proto-oncogene |
disease_progression |
ISO |
|
RGD |
PMID:26474280 |
RGD:11536137 |
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
|
|
G |
Cbr1 |
carbonyl reductase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21056497 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cbx2 |
chromobox 2 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chr10:104,278,517...104,287,384
Ensembl chr10:104,278,549...104,287,383
|
|
G |
Cbx4 |
chromobox 4 |
disease_progression |
ISO |
protein:increased expression:cytoplasm: |
RGD |
PMID:24838576 PMID:23943028 |
RGD:9586738, RGD:9586739 |
NCBI chr10:104,337,140...104,343,210
Ensembl chr10:104,336,876...104,356,706
|
|
G |
Cbx7 |
chromobox 7 |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:22041561 |
RGD:9587355 |
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr18:59,579,851...59,823,977
Ensembl chr18:59,580,768...59,824,400
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
RNA:increased expression:liver |
RGD |
PMID:27980102 PMID:22402625 PMID:12679798 PMID:27980102 |
RGD:14995459, RGD:14995927, RGD:14995468, RGD:14995459 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16284949 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment susceptibility |
ISO |
associated with alcoholic liver cirrhosis;DNA:SNP:promoter:-403G>A(human) DNA:polymorphisms:promoter:-403G>A,-28C>G (human) |
RGD |
PMID:28011329 PMID:21610221 PMID:22374185 |
RGD:14995306, RGD:14995338, RGD:14995333 |
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn1 |
cellular communication network factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17699798 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccna1 |
cyclin A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12029619 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccnb1 |
cyclin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
susceptibility |
ISO |
associated with Hepatitis B, Chronic;DNA:SNP:splice-site mutation:870G>A (human) CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (mouse) |
CTD RGD |
PMID:12029619 PMID:19919837 PMID:22649188 PMID:25822088 PMID:26189965 PMID:25851350 PMID:28100771 More...
|
RGD:14401586, RGD:127285675 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
severity susceptibility disease_progression |
ISO |
associated with hepatitis B associated with Chronic Hepatitis C;DNA:SNP: :rs1049606(human) DNA:hypermethylation:CpG site |
RGD |
PMID:33320844 PMID:22004425 PMID:31059558 PMID:33320844 |
RGD:151664743, RGD:151665169, RGD:151665109, RGD:151664743 |
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccne1 |
cyclin E1 |
ameliorates |
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12029619 PMID:22634754 PMID:17196522 PMID:29551768 PMID:28100771 |
RGD:2289277, RGD:153297807, RGD:127285675 |
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccnf |
cyclin F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Ccng1 |
cyclin G1 |
severity treatment disease_progression |
IGI ISO IEP |
protein:decreased expression:liver (human) protein:increased expression:liver (human) human cells in mouse model |
RGD |
PMID:25431954 PMID:27982046 PMID:22835824 PMID:19584283 PMID:33543294 PMID:23804702 PMID:23804702 PMID:26345095 PMID:24034575 More...
|
RGD:151356922, RGD:151361200, RGD:151361198, RGD:151356981, RGD:151356970, RGD:151356967, RGD:151356967, RGD:151356933, RGD:151356932 |
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccng2 |
cyclin G2 |
|
ISO |
|
RGD |
PMID:27982046 |
RGD:151361200 |
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16284949 |
|
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd274 |
CD274 molecule |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism associated with hepatitis B associated with hepatitis B |
CTD RGD |
PMID:22396772 PMID:21912640 PMID:30267213 |
RGD:41410800, RGD:40818240 |
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd276 |
Cd276 molecule |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16217749 |
|
NCBI chr 8:58,937,751...58,968,082
Ensembl chr 8:58,937,751...58,968,380
|
|
G |
Cd34 |
CD34 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
|
RGD |
PMID:19016771 |
RGD:2313413 |
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd5l |
Cd5 molecule-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
|
|
G |
Cd68 |
Cd68 molecule |
severity |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:28656201 |
RGD:40924686 |
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cdc20 |
cell division cycle 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25c |
cell division cycle 25C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc27 |
cell division cycle 27 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma |
ClinVar |
|
|
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
|
|
G |
Cdc45 |
cell division cycle 45 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdc6 |
cell division cycle 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdca2 |
cell division cycle associated 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdca3 |
cell division cycle associated 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdca5 |
cell division cycle associated 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
|
|
G |
Cdca8 |
cell division cycle associated 8 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:28284560 PMID:35693827 |
RGD:153344586 |
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdh1 |
cadherin 1 |
severity |
IDA ISO |
DNA:hypermethylation protein:decreased expression:liver mRNA:increased expression:liver |
RGD |
PMID:17295234 PMID:18837082 PMID:24840851 PMID:30697077 PMID:30697077 |
RGD:2289638, RGD:14402047, RGD:14402046, RGD:14402045, RGD:14402045 |
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh13 |
cadherin 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18425332 PMID:18553387 PMID:28284560 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
|
ISO |
protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:28284560 PMID:19136513 |
RGD:2316317 |
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk12 |
cyclin-dependent kinase 12 |
exacerbates |
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:31519701 |
RGD:151361172 |
NCBI chr10:83,201,177...83,256,906
Ensembl chr10:83,201,211...83,280,888 Ensembl chr10:83,201,211...83,280,888
|
|
G |
Cdk13 |
cyclin-dependent kinase 13 |
onset |
ISO |
DNA:amplification: : |
RGD |
PMID:22912832 |
RGD:155641228 |
NCBI chr17:47,251,145...47,344,675
Ensembl chr17:47,251,163...47,341,721
|
|
G |
Cdk14 |
cyclin-dependent kinase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22922871 |
|
NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:26189965 PMID:33841550 |
RGD:152998960 |
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISS |
OMIM:114550 |
MouseDO |
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20698225 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
severity |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:26606000 |
RGD:11354707 |
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
severity |
IEP ISO IDA |
Protein:increased expression:liver ClinVar Annotator: match by term: Hepatocellular carcinoma CTD Direct Evidence: marker/mechanism Protein:decreased expression:liver DNA:hypermethylation:exon DNA:hypermethylation:promoter |
ClinVar CTD RGD |
PMID:9185756 PMID:14508519 PMID:16317707 PMID:25741868 PMID:25780468 PMID:25822088 PMID:26225579 PMID:26467025 PMID:28284560 PMID:28492532 PMID:33010264 PMID:16317707 PMID:11301474 PMID:12359353 More...
|
RGD:1600816, RGD:1600816, RGD:8552680, RGD:1600822 |
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2a_v1 |
cyclin-dependent kinase inhibitor 2A, variant 1 |
|
IEP |
Protein:decreased expression:liver |
RGD |
PMID:16317707 |
RGD:1600816 |
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33010264 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
treatment severity |
ISO |
CTD Direct Evidence: marker/mechanism associated with alcoholism; protein:increased expression:liver protein:decreased expression:liver mRNA:increased expression:liver |
CTD RGD |
PMID:28284560 PMID:23292002 PMID:23292002 PMID:27314282 PMID:22390936 |
RGD:15090802, RGD:15090802, RGD:15090801, RGD:15090800 |
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16288022 PMID:21785164 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA: increased expression:liver (human) |
CTD RGD |
PMID:14563831 PMID:30659195 |
RGD:40903042 |
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14563831 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354
|
|
G |
Cenpa |
centromere protein A |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) |
CTD RGD |
PMID:28284560 PMID:21956590 |
RGD:36947377 |
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpe |
centromere protein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
|
|
G |
Cenpf |
centromere protein F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenpm |
centromere protein M |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 7:113,748,026...113,759,296
Ensembl chr 7:113,747,516...113,764,258
|
|
G |
Cenpu |
centromere protein U |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
|
|
G |
Cenpw |
centromere protein W |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
|
|
G |
Cep131 |
centrosomal protein 131 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr10:105,346,015...105,370,380
Ensembl chr10:105,346,015...105,370,380
|
|
G |
Cep164 |
centrosomal protein 164 |
susceptibility |
ISO |
associated with Chronic Hepatitis C;DNA:SNP: :rs573455 (human) |
RGD |
PMID:22004425 |
RGD:151665169 |
NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336
|
|
G |
Cep55 |
centrosomal protein 55 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Ces1d |
carboxylesterase 1D |
disease_progression |
ISO |
protein:decreased expression:liver (human) associated with tumor vascularization; protein:decreased expression:liver tumor (human) mRNA, protein:decreased expression:liver tumor (human) |
RGD |
PMID:24259486 PMID:30901224 PMID:19658107 |
RGD:152995276, RGD:152995286, RGD:152995279 |
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfp |
complement factor properdin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
|
|
G |
Chaf1b |
chromatin assembly factor 1 subunit B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
exacerbates |
ISO |
mRNA:increased expression:liver (human) protein:increased expression:liver (human) |
RGD |
PMID:28486105 PMID:26095183 |
RGD:153323299, RGD:11571740 |
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Chd5 |
chromodomain helicase DNA binding protein 5 |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:26517514 |
RGD:11537550 |
NCBI chr 5:162,848,273...162,898,997
Ensembl chr 5:162,848,394...162,896,291
|
|
G |
Ckap2l |
cytoskeleton associated protein 2-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
|
|
G |
Ckap4 |
cytoskeleton-associated protein 4 |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:increased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
|
|
G |
Cldn1 |
claudin 1 |
severity |
IEP |
protein:increased expression:liver (human) associated with liver cirrhosis;protein:increased expression:liver (human) protein:decreased expression:liver (human) |
RGD |
PMID:24815833 PMID:24696415 PMID:17270214 |
RGD:26884345, RGD:26884352, RGD:26884348 |
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Clec1b |
C-type lectin domain family 1, member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 4:162,847,978...162,856,291
Ensembl chr 4:162,848,010...162,856,291
|
|
G |
Clec4g |
C-type lectin domain family 4, member G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr12:1,780,370...1,785,027
Ensembl chr12:1,780,371...1,784,985
|
|
G |
Clec4m |
C-type lectin domain family 4 member M |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
|
|
G |
Clptm1l |
CLPTM1-like |
susceptibility disease_progression |
ISO |
DNA:SNPs::rs401681(human) DNA:SNP: :rs401681(human) |
RGD |
PMID:25339005 PMID:29042796 |
RGD:150530496, RGD:150537100 |
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr X:30,361,967...30,395,264
Ensembl chr X:30,361,967...30,395,349
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
|
|
G |
Cntnap4 |
contactin associated protein family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr19:40,568,684...40,861,879
Ensembl chr19:40,568,684...40,854,656
|
|
G |
Col15a1 |
collagen type XV alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
severity |
IDA |
Protein:increased expression |
RGD |
PMID:15739185 |
RGD:1600906 |
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Colec10 |
collectin subfamily member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 7:85,744,895...85,806,368
Ensembl chr 7:85,744,895...85,805,675
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15341023 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cops5 |
COP9 signalosome subunit 5 |
severity |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) |
CTD RGD |
PMID:20698225 PMID:26606000 |
RGD:11354707 |
NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
|
|
G |
Cox7b2 |
cytochrome c oxidase subunit 7B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr14:36,693,120...36,805,323
Ensembl chr14:36,693,105...36,805,523
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19229483 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: LIVER CELL CARCINOMA |
ClinVar |
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:25741868 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
|
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crhbp |
corticotropin releasing hormone binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 2:26,692,403...26,704,710
Ensembl chr 2:26,692,403...26,704,710
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
severity exacerbates |
ISO |
DNA:hypomethylation:promoter (human) protein:increased expression:liver (human) protein:increased expression: liver (human) |
RGD |
PMID:32724427 PMID:14969845 PMID:11412385 PMID:32760707 |
RGD:150524282, RGD:150524302, RGD:150524301, RGD:150524286 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2 |
colony stimulating factor 2 |
treatment |
ISO |
|
RGD |
PMID:12731087 |
RGD:10450243 |
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csk |
C-terminal Src kinase |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:9918913 |
RGD:5134372 |
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
|
|
G |
Csmd1 |
CUB and Sushi multiple domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr16:72,218,189...73,818,380
Ensembl chr16:72,218,503...73,817,614
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
susceptibility |
ISO |
protein:increased expression:CD4+ and CD8+ T cells: DNA:SNPs: :rs231775,rs231725(human) |
RGD |
PMID:28648905 PMID:23432218 |
RGD:14398741, RGD:14398742 |
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
|
|
G |
Ctnnb1 |
catenin beta 1 |
exacerbates severity susceptibility |
ISO |
DNA:mutation:exon 3 ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: AXIN1-related condition | ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA DNA:missense mutations:exon 3:multiple (human) DNA:Mutations:exon: protein:increased expression:liver: associated with hepatitis B;DNA:SNPs: :rs3864004,rs11564475(human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype: :rs3864004 (human) CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM RGD |
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10398436 PMID:10435629 PMID:10655994 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:19234609 PMID:20118494 PMID:21147764 PMID:21903672 PMID:23033978 PMID:23265383 PMID:24614104 PMID:24728327 PMID:24788118 PMID:25157968 PMID:25326635 PMID:25326669 PMID:25741868 PMID:25822088 PMID:26350204 PMID:26502894 PMID:26619011 PMID:26822237 PMID:27738331 PMID:27915094 PMID:27959697 PMID:28284560 PMID:28333917 PMID:28492532 PMID:28575650 PMID:29682453 PMID:30640974 PMID:31526516 PMID:10435629 PMID:27276713 PMID:19101982 PMID:19101982 PMID:28328801 PMID:26968103 More...
|
RGD:734850, RGD:150429592, RGD:14402052, RGD:14402052, RGD:14402040, RGD:14402039 |
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsb |
cathepsin B |
|
IDA |
|
RGD |
PMID:15641152 |
RGD:2315605 |
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctsl |
cathepsin L |
|
IDA |
|
RGD |
PMID:15641152 |
RGD:2315605 |
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Cux1 |
cut-like homeobox 1 |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:30561038 |
RGD:152985541 |
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866 Ensembl chr 4:20,107,311...20,425,866
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
disease_progression treatment |
ISO |
|
RGD |
PMID:28592115 PMID:27245433 PMID:28638480 |
RGD:27095889, RGD:27095899, RGD:27095898 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
treatment severity |
ISO |
human cells in mouse model protein:increased expression:liver (human) |
RGD |
PMID:30034941 PMID:33574707 |
RGD:151665331, RGD:151665327 |
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyld |
CYLD lysine 63 deubiquitinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21109933 |
|
NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15341023 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15341023 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
susceptibility |
ISO |
associated with hepatitis C; DNA:polymorphisms: : |
RGD |
PMID:11021356 |
RGD:124713413 |
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA, mRNA:SNP, Decreased expression:liver: rs2031920 (human) associated with alcohol dependence |
CTD RGD |
PMID:15162526 PMID:29765251 PMID:20364586 |
RGD:14700899, RGD:14700882 |
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
|
|
G |
Dab2ip |
DAB2 interacting protein |
severity |
ISO |
mRNA:decreased expression:liver (human) protein:decreased expression:liver (human) |
RGD |
PMID:31176165 PMID:22168621 |
RGD:151665110, RGD:151665148 |
NCBI chr 3:18,915,290...19,086,282
Ensembl chr 3:18,915,290...19,086,280
|
|
G |
Dbh |
dopamine beta-hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Dcn |
decorin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
severity |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:33173221 PMID:33173221 |
RGD:151347691, RGD:151347691 |
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
treatment disease_progression |
ISO |
|
RGD |
PMID:33969575 PMID:26362312 |
RGD:150429748, RGD:11086753 |
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Ddx3x |
DEAD-box helicase 3, X-linked |
exacerbates sexual_dimorphism |
ISO |
associated with hepatitis B; mRNA,protein:decreased expression:liver (human) |
RGD |
PMID:30297359 PMID:16301996 |
RGD:151356499, RGD:151356660 |
NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168
|
|
G |
Depdc1 |
DEP domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
|
|
G |
Depdc1b |
DEP domain containing 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
|
|
G |
Depdc5 |
DEP domain containing 5, GATOR1 subcomplex subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21725309 |
|
NCBI chr14:77,732,297...77,862,924
Ensembl chr14:77,732,297...77,862,794
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer |
ClinVar |
PMID:28492532 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
susceptibility |
ISO |
associated with hepatitis B; DNA:SNP: :rs1057035 T>C (human) |
RGD |
PMID:23868705 |
RGD:149735346 |
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dipk2b |
divergent protein kinase domain 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr X:4,205,486...4,274,939
Ensembl chr X:4,205,490...4,271,574
|
|
G |
Diras3 |
DIRAS family GTPase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 6:130,524,972...130,526,186
Ensembl chr 6:130,524,742...130,530,825
|
|
G |
Dlgap5 |
DLG associated protein 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Dmgdh |
dimethylglycine dehydrogenase |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
|
|
G |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 5:116,120,069...116,283,448
Ensembl chr 5:116,119,676...116,283,448
|
|
G |
Dnase1l3 |
deoxyribonuclease 1L3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:11844796 |
RGD:2289670 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO IEP |
protein:increased expression:liver: mRNA, protein:increased expression:liver |
RGD |
PMID:15885882 PMID:11844796 |
RGD:9588598, RGD:2289670 |
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
|
ISO IEP |
mRNA:increased expression:liver: mRNA, protein:increased expression:liver |
RGD |
PMID:15885882 PMID:11844796 |
RGD:9588598, RGD:2289670 |
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18019677 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dsn1 |
DSN1 component of MIS12 kinetochore complex |
disease_progression |
ISO |
|
RGD |
PMID:30136646 |
RGD:27372884 |
NCBI chr 3:145,652,741...145,668,025
Ensembl chr 3:145,652,737...145,665,856
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
|
|
G |
Dynlrb1 |
dynein light chain roadblock-type 1 |
|
ISO |
|
RGD |
PMID:11750132 |
RGD:13208527 |
NCBI chr 3:143,742,427...143,764,227
Ensembl chr 3:143,742,586...143,764,227
|
|
G |
Dynlrb2 |
dynein light chain roadblock-type 2 |
|
ISO |
|
RGD |
PMID:11750132 |
RGD:13208527 |
NCBI chr19:44,520,134...44,531,384
Ensembl chr19:44,520,134...44,531,387
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12029619 PMID:15565109 PMID:28284560 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f8 |
E2F transcription factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Eaf2 |
ELL associated factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20564326 |
|
NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Ect2 |
epithelial cell transforming 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
exacerbates |
ISO |
protein:increased expression, increased phosphorylation:liver (human) |
RGD |
PMID:28060762 |
RGD:153298915 |
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
disease_progression |
ISO |
protein:decreased expression:liver: |
RGD |
PMID:23936443 |
RGD:10401793 |
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
| |